ASGE Recognized Industry Associate (ARIA) Training Program for Sanofi | June 2022-Session 11B - Pathophysiology & Current Treatment of EoE Questions and Answers

Session 11B - Pathophysiology & Current Treatment of EoE Questions and Answers

Video Transcription

Video Summary

The video features a discussion between two doctors, Dr. Falk and Dr. Don Galbraith, about the use of biologics for Eosinophilic Esophagitis (EOE) treatment. The doctors discuss the lack of updated guidelines regarding the use of biologics in EOE management and the need for more research. They also mention the challenges of prescribing biologics, such as the high cost and insurance coverage. The discussion touches on the effectiveness of different treatments, including PPIs and topical steroids, and the importance of shared decision-making with patients. The doctors also briefly discuss the potential complications of EOE, such as esophageal tears, and the impact on patients' quality of life. The video concludes with a question about patient assistance programs for biologic medications, and the need for better communication between pharmaceutical representatives and healthcare providers.

Keywords

biologics

Eosinophilic Esophagitis

treatment

guidelines

research